A carregar...
Chimeric antigen receptors designed to overcome transforming growth factor‐β‐mediated repression in the adoptive T‐cell therapy of solid tumors
Adoptive cell therapy with chimeric antigen receptor (CAR)‐engineered T cells produced lasting remissions in the treatment of advanced, so far refractory B‐cell malignancies; however, the elimination of solid tumors remains so far elusive. The low efficacy of CAR T cells is thought to be due to the...
Na minha lista:
| Publicado no: | Clin Transl Immunology |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589154/ https://ncbi.nlm.nih.gov/pubmed/31236274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1064 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|